Esperion

[anonymous]

The lackeys in the bleachers with more buffoonery comments. Always with the insults and no clinical discussion and no answer as to why stock was 78.00 in 2020. What happened Scientific Lackey Boy?

Bump up in the stock today.

Not a good move.

Tomorrow will be the day of reckoning .

 

[anonymous]

Please let me know when and where the Scientific Hired Highly Tenured Customer Facing Team and Lipid Trained Expert alumni reunion is.

Thank you

 

[anonymous]

The stock is down dummy. Learn how to read a chart. Your supposed to be a Scientific Hire!!

 

[anonymous]

The stock is down dummy. Learn how to read a chart. Your supposed to be a Scientific Hire!!

Oh, Jezebel Karen!!

 

[anonymous]

Down to $6.16. Butterflies in the stomach with data coming. Are we screwed.

 

[anonymous]

Down to $6.16. Butterflies in the stomach with data coming. Are we screwed.

Again, Karen, you do not work here.

 

[anonymous]

Everyone on our team are very nervous about ACC. Since nothing has gone right from the start this causes concern. RBL's are clueless and talk out both sides of their mouths. We just want some decent data and some stability. Is that so much to ask??

 

[anonymous]

Everyone on our team are very nervous about ACC. Since nothing has gone right from the start this causes concern. RBL's are clueless and talk out both sides of their mouths. We just want some decent data and some stability. Is that so much to ask??

Oh, Karen, you do not work here.

 

[anonymous]

We're really struggling inches field. Morale is low as our futures hang in the balance over next few days.

 

[anonymous]

We're really struggling inches field. Morale is low as our futures hang in the balance over next few days.

COUNTDOWN 4 DAYS!! Don’t be a whimp I’m excited!!

 

[anonymous]

We're really struggling inches field. Morale is low as our futures hang in the balance over next few days.

Sure, Karen.

 

[anonymous]

Will see what happens. Plenty of warning well ahead of time.

 

[anonymous]

If this drug does not get any CV benefit, it is toast. A one drug company for statin intolerant patients. There are loads of generics that can do the same. If they price it high or don’t get favorable coverage, it is a tough sell.

It already has…showed significant for 4 point MACE endpoint! By how much is the question when presented. So get your facts straight before blabbing!

 

[anonymous]

BTW the stock is done 5% already today. Not a good intro for Notso Clear.

 

[anonymous]

BTW the stock is done 5% already today. Not a good intro for Notso Clear.

Oh, Karen.

 

[anonymous]

BTW the stock is done 5% already today. Not a good intro for Notso Clear.

Jealous little man aren’t you? Didn’t make the cut and still on this site. Hilarious

 

[anonymous]

Get your facts straight, lol. So when did facts ever be involved with Esperion? The reps have been talking out their asses for 3 years. What's a few more days of selling misery.

 

[anonymous]

ESPR held the study results for months. Why ?
All studies a biased in favor of the company sponsoring. Any idiot knows this.
Companies then bend themselves into a pretzel to massage the results to appear Clinically beneficial.
It is a game to get reimbursement.
Patient is only a means for billing.

 

[anonymous]

Get your facts straight, lol. So when did facts ever be involved with Esperion? The reps have been talking out their asses for 3 years. What's a few more days of selling misery.

 

[anonymous]

ESPR held the study results for months. Why ?
All studies a biased in favor of the company sponsoring. Any idiot knows this.
Companies then bend themselves into a pretzel to massage the results to appear Clinically beneficial.
It is a game to get reimbursement.
Patient is only a means for billing.